Sattar, N., McLaren, J., Kristensen, S. L., Preiss, D., & McMurray, J. J. (2016). SGLT2 Inhibition and cardiovascular events: Why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia.
Citação norma ChicagoSattar, Naveed, James McLaren, Søren L. Kristensen, David Preiss, and John J. McMurray. "SGLT2 Inhibition and Cardiovascular Events: Why Did EMPA-REG Outcomes Surprise and What Were the Likely Mechanisms?" Diabetologia 2016.
Citação norma MLASattar, Naveed, et al. "SGLT2 Inhibition and Cardiovascular Events: Why Did EMPA-REG Outcomes Surprise and What Were the Likely Mechanisms?" Diabetologia 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.